Assessment of the safety and efficacy of intravenous versus topical tranexamic acid in patients undergoing primary total hip and knee arthroplasty surgeries with respect to decreasing peri-operative blood loss and blood transfusion rates: a prospective and comparative study
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20240418Keywords:
Tranexamic acid, Arthroplasty, Intravenous, Topical, THR, TKR, Hemoglobin, Blood transfusionAbstract
Background: Synthetic antifibrinolytic agent like tranexamic acid has been increasingly used in Arthroplasty surgeries to decrease the peri-operative blood loss. The current study was undertaken to compare the efficacy between the intravenous and Topical route of TXA in deceasing the blood loss and transfusion rate in patients undergoing primary total hip and knee arthroplasty (THR and TKR) surgeries.
Methods: A total of 120 patients were enrolled in the study with 60 each undergoing THR and TKR surgeries with 30 each given TXA in IV and Topical routes. Outcomes were assessed in terms of mean 24 hours drain output, mean blood loss, mean drop in hemoglobin blood transfusion rate.
Results: The mean drain output was more in the IV group in both THR and TKR patients (p>0.05). The mean blood loss was more in the Topical group in both THR and TKR patients (p>0.05). The mean drop in hemoglobin was more in the Topical group, with the difference being significant in the THR patients (p<0.05) and being insignificant in TKR patients (p>0.05). In IV group 9 patients (15%) and in Topical group 25 patients (41.67%) needed blood transfusions, the difference being statistically significant.
Conclusions: Both IV and Topical routes of TXA are equally effective in decreasing the peri-operative blood loss and transfusion rates in patients undergoing primary arthroplasty surgeries, with IV route having slightly upper hand as compared to the Topical route.
References
Varacallo M, Johanson NA. Total Knee Arthroplasty. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2018.
Lagoo-Deenadayalan SA, Newell MA, Pofahl WE. Common Perioperative Complications in Older Patients. In: Rosenthal RA, Zenilman ME, Katlic MR, editors. Principles and Practice of Geriatric Surgery. New York, NY: Springer New York; 2011: 361-76.
Maradit KH, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, et al. Prevalence of Total Hip and Knee Replacement in the United States. J Bone Joint Surg Am. 2015;97(17):1386-97.
Oremus K. Tranexamic acid for the reduction of blood loss in total knee arthroplasty. Ann Translat Med. 2015;3(1):S40.
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51: 224-32.
Ollivier JE, Van Driessche S, Billuart F, Beldame J, Matsoukis J. Tranexamic acid and total hip arthroplasty: optimizing the administration method. Ann Translat Med. 2016;4(24):530.
Wong J, Abrishami A, El Beheiry H, Mahomed NN, RoderickDavey J, Gandhi R, et al. Topical application of tranexamicacid reduces postoperative blood loss in total kneearthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010;92(15):2503-13.
Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Mosteffective regimen of tranexamic acid in knee arthroplasty: aprospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012; 470(9):2605-12.
Benoni G, Lethagen S, Fredin H. The effect of tranexamic acidon local and plasma fibrinolysis during total kneearthroplasty. Thromb Res. 1997;85(3):195-206.
Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical Intra-Articular Compared with Intravenous Tranexamic Acid to Reduce Blood Loss in Primary Total Knee Replacement: A Double-Blind, Randomized, Controlled, Noninferiority Clinical Trial. JBJS. 2014;96(23):1937.
Keyhani S, Esmailiejah AA, Abbasian MR, Safdari F. Which route of tranexamic acid administration is more effective to reduce blood loss following total knee arthroplasty?. Thromb Res. 2016;4(1):5.
Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplast. 2014; 29(8):1528-31.
Bobin Mi, Liu G, Zhou W, Lv H, Liu Y, Zha K, et al. Intra-articular versus intravenous tranexamic acid application in total knee arthroplasty: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2017;137(7):997-1009.
Wei W, Dang S, Duan D and Wei L. Comparison of intravenous and topical tranexamic acid in total knee arthroplasty. BMC Musculoskelet Disord. 2018;19: 191.
Abdel MP, Chalmers BP, Taunton MJ, Pagnano MW, Trousdale RT, Sierra RJ, et al. Intravenous versus topical tranexamic acid in total knee arthroplasty: both effective in a randomized clinical trial of 640 patients. J Bone Joint Surg. 2018;100(12):1023-9.
Chen Y, Chen Z, Cui S, Li Z, Yuan Z. Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. Medicine. 2016;95(41):e4656.
Fu Y, Shi Z, Han B, Ye Y, You T, Jing J, et al. Comparing efficacy and safety of 2 methods of tranexamic acid administration in reducing blood loss following total knee arthroplasty: A meta-analysis. Medicine. 2016;95(50):e5583.
Subramanyam KN, Khanchandani P, Tulajaprasad PV, Jaipuria J, Mundargi AV. Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: a prospective randomized double-blind equivalence trial. Bone Joint J. 2018;100(2):152-60.
Zyla M, Bielski K, Dabrowski M, Wieczorek W, Kamińska H, Czyzewski L, et al. Skills and attitudes toward intraosseous access in cardiopulmonary resuscitation among nursing personnel. J Bone Joint Surg. 2018;31:27-31.
Li J, Zhang Z, Chen J. Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: A meta-analysis. Medicine. 2016;95(36):e4689.
